Durvalumab and SNDX-6532 Following Chemo or Radio-Embolization for Patients With Intrahepatic Cholangiocarcinoma
Clinical trial NCT04301778 · COMPLETED
Trial details
- NCT number
- NCT04301778
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-24
- Primary completion
- 2022-11-04
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.